I agree that this site is using cookies. You can find further informations here.
X
Randazzo, Dina
100  results:
Search for persons X
?
1

Targeting the IL4 receptor with MDNA55 in patients with rec..:

Sampson, John H ; Singh Achrol, Achal ; Aghi, Manish K...
Neuro-Oncology.  25 (2023)  6 - p. 1085-1097 , 2023
Link: https://doi.org/10.1093/..
 
?
2

CTNI-52. SURVIVAL OUTCOMES IN RECURRENT GLIOBLASTOMA (RGBM)..:

Sampson, John ; Achrol, Achal Singh ; Aghi, Manish...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v87-v87 , 2023
Link: https://doi.org/10.1093/..
 
?
3

CTIM-28. MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOT..:

Sampson, John ; Achrol, Achal Singh ; Aghi, Manish K...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi56-vi57 , 2021
Link: https://doi.org/10.1093/..
 
?
4

CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGE..:

Batich, Kristen ; Mitchell, Duane ; Healy, Patrick...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi51-vi51 , 2021
Link: https://doi.org/10.1093/..
 
?
5

EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR T..:

Thompson, Eric ; Landi, Daniel ; Archer, Gerald...
Neuro-Oncology.  23 (2021)  Supplement_1 - p. i46-i46 , 2021
Link: https://doi.org/10.1093/..
 
?
6

BIOM-20. TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE ..:

Brown, Michael ; Zhang, Gao ; Stevenson, Kevin...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi14-vi15 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Very low mutation burden is a feature of inflamed recurrent..:

Gromeier, Matthias ; Brown, Michael C. ; Zhang, Gao...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
8

CTIM-23. A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATE..:

Desjardins, Annick ; Randazzo, Dina ; Chandramohan, Vidya...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii38-ii38 , 2020
Link: https://doi.org/10.1093/..
 
?
9

Patterns of relapse after successful completion of initial ..:

Patel, Mallika P. ; Kirkpatrick, John P. ; Johnson, Margaret O....
Journal of Neuro-Oncology.  147 (2020)  2 - p. 477-483 , 2020
Link: https://doi.org/10.1007/..
 
?
10

QOLP-05. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAU..:

Patel, Mallika ; Peters, Katherine ; Lipp, Eric...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii175-ii175 , 2020
Link: https://doi.org/10.1093/..
 
?
11

QOLP-24. ENGAGING PATIENTS AND CAREGIVERS TO IMPROVE THE IM..:

Peters, Katherine ; Randazzo, Dina ; Johnson, Margaret...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii180-ii180 , 2020
Link: https://doi.org/10.1093/..
 
?
12

CTIM-13. CLINICAL EFFICACY OF MDNA55, AN INTERLEUKIN-4 RECE..:

Sampson, John ; Achrol, Achal ; Aghi, Manish...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii35-ii35 , 2020
Link: https://doi.org/10.1093/..
 
?
13

NCOG-23. PATTERNS OF DISTRESS IN OLDER PATIENTS WITH GLIOBL..:

Johnson, Margaret ; Herndon II, James ; Lipp, Eric...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii134-ii134 , 2020
Link: https://doi.org/10.1093/..
 
?
14

NCOG-38. CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIE..:

Peters, Katherine ; Lipp, Eric ; Broadwater, Gloria...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii137-ii137 , 2020
Link: https://doi.org/10.1093/..
 
?
15

CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT..:

Thompson, Eric ; Landi, Daniel ; Thompson, Eric...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii37-ii37 , 2020
Link: https://doi.org/10.1093/..
 
1-15